Key facts
- It has raised $600K; the latest was Accelerator/Incubator in Oct 2025.
- Notable investors include CzechInvest, Dendis Capital, Fond10x, Jinej Fond, Lumus Investment — 7 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for HTG medical
- ·The full record, as it builds
Funding rounds
No funding rounds for HTG medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About HTG medical
Developer of a medical technology platform designed to automate urine output monitoring and improve efficiency in intensive care units. The company offers real-time data collection, automated fluid tracking, and integration with hospital systems, enabling hospitals and clinics to reduce manual workload, improve patient safety, and support sustainable practices.
- Sector
- Healthcare
- HQ
- Prague, Czech Republic
- Founded
- 2021
- Employees
- 9
- Website
- htgmedical.com/
- Ownership
- Privately Held (backing)
HTG medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in HTG medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on HTG medical in its N-PORT filings yet. We sweep new filings monthly.